Cardiac Failure
68
10
11
39
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.3%
7 terminated out of 68 trials
84.8%
-1.7% vs benchmark
13%
9 trials in Phase 3/4
18%
7 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (68)
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure
Cardiac Remodelling Following Endovascular Repair of the Aorta
Study of Platelet Population Changes Under Circulatory Support With ECMO
Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
Landiolol in Mitral Valve Surgery
Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment.
A Preliminary Study for INFORMED
The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
Remote Patient Monitoring for Patients With Heart Failure in France
Physical Exercise and Telephone Follow-up Mediated by Telerehabilitation
Non-invasive Monitoring of Mixed Venous Oxygen Saturation Using the Capnodynamic Method in Adults
Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial
Heart Failure Insomnia Treatment Study
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
Efficacy of AI EF Screening by Using Smartphone Application Recorded PLAX View Cardiac Ultrasound Video Clips